• Human iPSC-derived cells can model normal cells for in vitro assessment of on/off-target CAR T cell binding and cytotoxicity. • Human iPSC-derived cells provide a consistent model various human cell types that might be unexpected CAR T cell targets. • Orthogonal data sets provide a weight of evidence approach for in vitro assessment of CAR T cell binding and cytotoxicity.